UBS Maintains Buy on Ovintiv, Lowers Price Target to $75

Benzinga Newsdesk www.benzinga.com Negative 50.0%

Neg 50% Neu 0% Pos 0%

UBS analyst Josh Silverstein maintains Ovintiv (NYSE:OVV) with a Buy and lowers the price target from $76 to $75.

Comments

No comments yet. Be the first!